Table 3.
Relationship between the clinical form and positivity for autoantibodies in participants diagnosed with leprosy and treated in Marabá, Pará
| Autoantibody | Clinical Form | |||||||
|---|---|---|---|---|---|---|---|---|
| I (n = 1) |
T (n = 5) |
B (n = 26) |
L (n = 9) |
|||||
| ANA HEp-2 | ||||||||
| Positive | 0 | 0 | 2 | 4 | ||||
| Negative | 1 | 5 | 24 | 5 | ||||
| p-value | 0.1683 | 0.0148* | ||||||
| Anti-cardiolipin IgG | ||||||||
| Positive | 0 | 0 | 0 | 1 | ||||
| Negative | 1 | 5 | 26 | 8 | ||||
| p-value | 0.3659 | 0.2195 | ||||||
| Anti-β2 glycoprotein IgG | ||||||||
| Positive | 0 | 0 | 1 | 1 | ||||
| Negative | 1 | 5 | 25 | 8 | ||||
| p-value | 1.0000 | 0.3951 | ||||||
| Anti-β2 glycoprotein IgM | ||||||||
| Positive | 0 | 0 | 0 | 6 | ||||
| Negative | 1 | 5 | 26 | 3 | ||||
| p-value | 0.0011* | 0.0000* | ||||||
| Rheumatoid Factor | ||||||||
| Positive | 0 | 0 | 0 | 1 | ||||
| Negative | 1 | 5 | 26 | 8 | ||||
| p-value | 0.3659 | 0.2195 | ||||||
*statistically significant p < 0,05 (Fisher’s exact test). ANA: anti-cell autoantibodies; I: indeterminate; T: tuberculoid; B: borderline; L: lepromatous